Boyu Capital

Ouroboros Medicines is a biotechnology company that specializes in immunology and focuses on treating long-term immune-mediated illnesses. The company addresses chronic immune-mediated conditions directly by integrating scientific knowledge, a proven history of progressing cell-depleting treatments through clinical trials, and a strong pipeline.

Timberlyne Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes revolutionary medicines for autoimmune illnesses. The company utilizes its team's experience in drug development to secure top-tier assets focused on promising targets, and implementing them in disease areas with considerable unmet needs.

Seek Pet Foods is an original equipment manufacturer and original design manufacturer specializing in the development and production of pet food and related products. The company utilizes innovative technologies, including American micropowder puffing and fresh meat emulsification, to create nutritious pet food. By incorporating locally sourced, ecologically sustainable fresh chicken and duck meat along with other natural ingredients, Seek Pet Foods aims to provide customers with healthy options for their pets.

Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

Shuaike is a company specializing in pet supplies and food. The brand is derived from the English "seek", adheres to the brand management philosophy of "only natural fresh meat", and aims to make the best natural and healthy food for pets all over the world. American micro powder puffing technology and fresh meat emulsification technology, combined with local fresh chicken and duck meat, natural food, organic vegetables, fruits, and other nutrients to extract natural fresh meat pet food, now export dog food and cat food Shuikesaijia Natural cat and dog food.

Xiaohongshu, founded in 2013 and based in Shanghai, China, is a lifestyle sharing platform that allows users to share experiences through text, images, and videos. Initially aimed at assisting overseas travelers with shopping, it has transformed into a vibrant community focused on various lifestyle areas, including cosmetics, fashion, food, travel, entertainment, reading, fitness, and childcare. The platform serves as a social e-commerce space where users can post their favorite products, share shopping experiences, and discover global merchandise, particularly in luxury and beauty sectors. By fostering user-generated content, Xiaohongshu encourages a collaborative environment for lifestyle enthusiasts to exchange insights and recommendations.

GDS International portfolio currently comprises approximately 480 MW of data center capacity in service and under construction and an additional 590 MW held for future development across strategic locations in Hong Kong, Singapore, Malaysia (Johor), Indonesia (Batam), and Japan (Tokyo).

Chunqing Technology is a company that create new generation of electric vehicles powered by alcohol and hydrogen. Chunqing Technology creates, manufactures, and distributes alcohol and hydrogen energy for the next generation of electric automobiles.

Tai Hydrogen Energy is an energy solutions provider that focuses on the core products and application of clean energy based on green electricity and green hydrogen. It is a subsidiary of Chint Group.

Jingkong Energy is an energy system research and development platform. They offer services for the development of smart power supply, electric power and energy storage, and fuel cell fields.

Doujin Culture is a cross-border e-commerce firm offers significant support for brands looking to expand internationally.

Quasar specializes in the manufacture of products for the medical device market, including catheters, electronics, and disposables. From initial design to mass production, Quasar’s integrative approach ensures superior outcomes, top quality, and cost-efficiency for clients. Founded in Hong Kong in 1988 by Boaz Amitai, the company was created to serve as a connection between its European, American, and Israeli customers and Chinese electronics manufacturers.

Farizon Auto, established in 2014 by Geely's New Energy Commercial Vehicles Group, is a pioneering brand in China's new energy commercial vehicle sector. Over the years, Farizon has developed a range of urban and highway commercial vehicles, focusing on pure electric and range-extended electric power systems, as well as liquid hydrogen and methanol power technologies. Its product offerings include heavy trucks, light trucks, small and mini trucks, light commercial vehicles, and buses, catering to various commercial applications. Farizon operates the largest new energy commercial vehicle research institute in China, supported by over 2,000 research engineers globally. Aiming to lead the green commercial revolution, Farizon integrates intelligent transportation technology with a green energy supply network, providing comprehensive services throughout the vehicle life cycle. The company's vision includes contributing to zero-carbon land transport in China through innovative solutions in new energy commercial vehicles.

Tianbing Technology is an advanced aerospace propulsion system supplier and aerospace vehicle provider. Tianbing Technology independently develops the next-generation ambient temperature green HCP liquid propellant and minimalist aerospace propulsion system. As an upgraded product of traditional chemical propulsion system, it can meet cost-effective aerospace. Advance system supporting needs. The next-generation green HCP aerospace propulsion system, first tested by Tianbing Technology, can be used in the small-vehicle main power and launch vehicle upper-level propulsion system.

Animoca Brands is a metaverse and gaming venture capital firm that focuses on driving digital property rights to gamers and internet users through NFTs. It utilizes gamification and blockchain to develop and market a portfolio of mobile applications, games, and additional products oriented to educational learning to ensure transparency, security, and new business models.

Frontera Therapeutics is a company specializing in adeno-associated virus (AAV) gene therapy, focused on developing and commercializing cost-effective recombinant virus-based therapies. The company aims to create a scalable platform that produces high-quality, affordable rAAV therapies for a range of genetic disorders, including ophthalmic, liver, metabolic, and neuromuscular diseases. Frontera Therapeutics has a diverse product pipeline that encompasses multiple therapeutic areas, with various candidates at different stages of development. By prioritizing affordability and quality, the company seeks to enhance the lives of patients through innovative genetic therapies.

Evat Master is a software-as-a-service (SaaS) platform that focuses on delivering independent European VAT declarations specifically for cross-border e-commerce businesses. The platform streamlines the tax reporting process, enabling users to complete all required tax procedures online. By offering a user-friendly interface, Evat Master simplifies the complexities of VAT compliance, making it easier for businesses engaged in international trade to manage their tax obligations effectively.

Shuaike is a company specializing in pet supplies and food. The brand is derived from the English "seek", adheres to the brand management philosophy of "only natural fresh meat", and aims to make the best natural and healthy food for pets all over the world. American micro powder puffing technology and fresh meat emulsification technology, combined with local fresh chicken and duck meat, natural food, organic vegetables, fruits, and other nutrients to extract natural fresh meat pet food, now export dog food and cat food Shuikesaijia Natural cat and dog food.

Moan Technology is a company in the field of enterprise services. It is committed to integrating threat intelligence technology and artificial intelligence technology into the enterprise security defense system, providing enterprises with a total security solution in the cloud computing and IoT era.

ArriVent Biopharma is a clinical-stage biopharmaceutical company focused on developing innovative treatments for currently untreatable cancers. The company is committed to addressing unmet medical needs in oncology by leveraging its team's extensive drug development experience. ArriVent aims to maximize the potential of its lead candidate, furmonertinib, while advancing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates. With an initial emphasis on solid tumors, ArriVent seeks to bring differentiated medicines from development through to commercialization, ultimately improving patient outcomes in cancer treatment.

Recurrent.ai is a Chinese company that specializes in AI-enabled corporate services aimed at enhancing sales efficiency. The company utilizes advanced machine learning technologies to analyze sales calls and conversations, transforming voice interactions into text for comprehensive analysis. Its offerings include a self-study engine for sales dialogue, which allows businesses to generate detailed big data dialogue analysis reports and maintain customer portrait records. By automating these processes, Recurrent.ai helps organizations reduce time and labor costs, improve sales conversion rates, and enhance overall decision-making capabilities.

In many companies, culture may be just a loud slogan hanging on the wall; in Jinke, culture has long been a kind of spirit flowing in every inch of the body of the enterprise, and a belief from every employee. . The culture of endless life is becoming an important guarantee for the execution of the Jinke team and an inexhaustible driving force for the company's continued growth.

Vision Medicals specializes in pathogenic gene diagnostic services, aiming to enhance medical treatment precision for infections. The company utilizes advanced technologies such as high-throughput sequencing-based pathogen metagenomics and CRISPR for rapid diagnostics, significantly improving the ability to detect clinical pathogens and reducing reporting times. Vision Medicals has developed proprietary nucleic acid enrichment technology to identify pathogenic micronucleic acids in clinical samples. By leveraging an extensive database of pathogen detection, the company has established a comprehensive pathogen macro, supported by a genomics intelligent analysis and reporting system. Through its focus on research and development, Vision Medicals seeks to lead the medical diagnostic industry with innovative detection technology platforms that enhance the efficiency and accuracy of medical diagnoses.

J&T Express is a logistics service provider focused on express delivery and courier services, primarily supporting the e-commerce sector. Founded in 2015 and headquartered in Jakarta, Indonesia, the company operates automated sorting warehouses in Indonesia and Singapore. J&T Express has established itself as a leading player in the express delivery market across Southeast Asia, offering services in 13 countries. By partnering with major e-commerce platforms, J&T facilitates the growth of its clients, enabling them to expand into new markets effectively. Its commitment to efficient logistics and innovative solutions positions J&T Express as a key player in the rapidly evolving logistics landscape.

Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

Edge Medical Robotics, Inc. is a Shenzhen, China-based company that specializes in the design and development of advanced surgical equipment. Founded on May 4, 2017, the company is dedicated to researching and promoting cutting-edge smart technologies aimed at enhancing surgical safety and treatment efficacy. By focusing on the pursuit of excellence and refinement in its products, Edge Medical Robotics seeks to elevate health standards and improve overall social health outcomes.

Zeekr develops and manufactures premium electric vehicles and automobiles. It specializes in the fields of electronics, automotive and electric vehicles.

MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and comprehensive medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a cohesive ecosystem that benefits all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust Health aims to deliver affordable, personalized healthcare solutions to families. In addition to its insurance offerings, the company focuses on improving the management of medical expenses and enhancing patient access to necessary services through innovative payment solutions. MediTrust Health's commitment to addressing the complexities of medical financing and providing diverse healthcare benefits positions it as a significant player in the healthcare industry.

Pulse is a health care service provider that assess coronary physiology and biomechanics through innovative techniques.

Pulse Medical Technology develops innovative technology for the diagnosis and optimal treatment of pan-vascular diseases.

Polarisic specializes in the development of advanced measurement and imaging chip products, primarily utilizing single-photon avalanche diode (SPAD) technology. The company offers two main product lines: direct photon time-of-flight (dToF) measurement chips and low-light imaging chips. The dToF chips are designed for applications such as Unmanned Aerial Vehicle (UAV) height determination, obstacle avoidance, navigation for automated guided vehicles (AGVs), and smart perception in the Internet of Things (IoT). The low-light imaging chips feature high sensitivity and pixel digitization capabilities, making them suitable for night vision systems, security monitoring, smart industrial measurement, and enhanced smartphone photography. Polarisic is recognized for its technological innovations in dToF detection, high-speed digital processing, detection algorithm fusion, and system integration.

ArriVent Biopharma is a clinical-stage biopharmaceutical company focused on developing innovative treatments for currently untreatable cancers. The company is committed to addressing unmet medical needs in oncology by leveraging its team's extensive drug development experience. ArriVent aims to maximize the potential of its lead candidate, furmonertinib, while advancing a pipeline of novel therapeutics, including next-generation antibody-drug conjugates. With an initial emphasis on solid tumors, ArriVent seeks to bring differentiated medicines from development through to commercialization, ultimately improving patient outcomes in cancer treatment.

Launched in 2016, Soul App is now one of the leading social networking applications in China. With a robust user base among Chinese Gen Z, Soul was designed to empower self-value expression and foster genuine relationships based on interest graphs and AI algorithms. Soul aspires to build a virtual social playground for its users to socialize, connect and maintain relationships free from the geographic and social constraints. Soul is the first social networking platform in China that requires all users to interact through avatars, and has a unique business model driven by the integration of intensive user interactions and an engaging community. Soul distinguishes itself from other peers with focus on virtual identities, open-ended relationships based on interest graphs, extensive user generated content (UGC), decentralized content distribution and its proprietary technologies. Nowadays, Soul pioneers in embracing the AI technologies in the social networking industry to meet the evolving social demand from the younger generation. In 2020, Soul kicked off its AIGC technology R&D. In 2023, Soul launched a proprietary large language model (LLM), Soul X, and has seamlessly embedded AI capabilities across use cases on its platform, which epitomizes Soul's product philosophy of the “Synergic Model-application Interplay”.

J&T Express is a logistics service provider focused on express delivery and courier services, primarily supporting the e-commerce sector. Founded in 2015 and headquartered in Jakarta, Indonesia, the company operates automated sorting warehouses in Indonesia and Singapore. J&T Express has established itself as a leading player in the express delivery market across Southeast Asia, offering services in 13 countries. By partnering with major e-commerce platforms, J&T facilitates the growth of its clients, enabling them to expand into new markets effectively. Its commitment to efficient logistics and innovative solutions positions J&T Express as a key player in the rapidly evolving logistics landscape.

Klook is a prominent travel and leisure e-commerce platform that facilitates the discovery and booking of a wide variety of experiences and services for travelers. Users can explore and reserve activities such as tours, theme park tickets, cultural experiences, and adventure outings in numerous destinations. The platform also offers essential travel services, including public transport passes, airport transfers, car rentals, and SIM cards or eSIMs, ensuring seamless connectivity for users. Additionally, Klook allows travelers to book accommodations, making it a comprehensive solution for trip planning. Food enthusiasts can enhance their culinary experiences through dining reservations, food tours, and restaurant vouchers available on the platform.

Lalamove, originally launched as EasyVan in December 2013 in Hong Kong, is an on-demand logistics platform that connects customers with driver-partners for rapid delivery services. Operating in 21 markets across Asia and Latin America, the company serves over 7 million customers and boasts a network of more than 700,000 drivers. Lalamove has transformed traditional van hiring by enabling instant matches between customers and drivers, often within 12 seconds. The platform facilitates same-day deliveries, typically completing local deliveries within 55 minutes. Additionally, Lalamove provides features such as real-time vehicle tracking and driver ratings, allowing businesses to efficiently scale their delivery operations while optimizing drivers’ routes and earnings.

SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration – neurovascular inflammation, proteinopathy, and immune response. The company aims to develop disease-modifying treatment options for Alzheimer’s disease, Parkinson’s disease, and other devastating CNS diseases.

D3 Bio is a biotechnology company dedicated to the discovery, development, and registration of innovative medicines in oncology and immunology. The company aims to address existing gaps in conventional treatments by utilizing clinical and market data to identify areas for improvement. D3 Bio employs unique drug development methodologies that target new diseases and delivery methods, ultimately providing patients with alternative therapeutic options in these critical areas of healthcare.

Founded in 2012, Yuanfudao is the largest online live courseplatform servicing primary and secondary school students in China. With a paying userbase of over 1 million, Yuanfudao offers a comprehensive curriculum spanning fromprimary school English, Mathematical Olympiad to all-subject courses in secondaryschool. Its unique online feature and large pool of quality teachers enable students toaccess live online tutoring at home taught by national renowned teachers, benefitinghundreds of thousands of students across the country.

Antengene Corporation is a clinical-stage biopharmaceutical company based in Shanghai, China, founded in 2016. The company specializes in the development of innovative oncology therapies, focusing on treatments for various types of cancers, including hematologic malignancies and solid tumors. Antengene's product portfolio includes ATG-010 (selinexor), which targets XPO1 for treating multiple myeloma and DLBCL, and ATG-008 (onatasertib), an mTOR kinase inhibitor for advanced solid tumors. The company’s pipeline also features several compounds in various stages of development, such as ATG-016, ATG-527, ATG-019, and ATG-017, each targeting specific cancer pathways. In addition to its clinical programs, Antengene is involved in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics, aiming to address unmet medical needs in the oncology field across Asia.

Yatsen Holding Limited is a beauty company based in Guangzhou, China, specializing in the development and sale of cosmetics and skincare products. The company operates under several brands, including Perfect Diary, Little Ondine, and Abby’s Choice. It offers a diverse range of products, including color cosmetics, eye makeup, lip makeup, face makeup, skincare, and nail products, as well as makeup tools and accessories. Yatsen has established itself as a leader in the online retail space, with Perfect Diary recognized as the top color cosmetics brand in China shortly after its launch. Founded in 2016, the company has expanded its offerings to include perfumes and beauty devices, and it sells its products through both physical stores and online channels.

Founded in 2012, Yuanfudao is the largest online live courseplatform servicing primary and secondary school students in China. With a paying userbase of over 1 million, Yuanfudao offers a comprehensive curriculum spanning fromprimary school English, Mathematical Olympiad to all-subject courses in secondaryschool. Its unique online feature and large pool of quality teachers enable students toaccess live online tutoring at home taught by national renowned teachers, benefitinghundreds of thousands of students across the country.

PDD Holdings (Nasdaq: PDD) is a multinational commerce group that owns and operates a portfolio of businesses. PDD Holdings aims to bring more businesses and people into the digital economy so that local communities and small businesses can benefit from the increased productivity and new opportunities. PDD Holdings has built a network of sourcing, logistics, and fulfillment capabilities, that support its underlying businesses.

Kuaishou Technology, founded in 2011 and based in Beijing, China, operates an online video and photo sharing application known as Kuaishou. The platform enables users to broadcast their daily activities and engage with a global audience through short videos, photos, and live streams. Kuaishou aims to enhance individual happiness by leveraging big data and artificial intelligence technology, promoting equal opportunities through its algorithms and ethical values. The app empowers everyday individuals in China to share their experiences and connect with fans worldwide. Additionally, Kuaishou has an international counterpart, Kwai, which offers similar features tailored for users outside of China. With an average of 275.9 million daily active users, Kuaishou generates revenue by selling virtual items, online marketing, and earning commissions from e-commerce transactions on its platform.

Chengjia Apartment is a rental start-up that provides different product choices for apartments, hotels, and homestays. Chengjia Apartment extends the business scope to weekly rent, monthly rent, and long-term rent. The company creates a high-quality living environment with ingenuity, take care of every guest with hotel-style service, and creates a warm, comfortable, and temperature-friendly home. Chengjia Apartment is jointly established by China Living Hotel Group and IDG Capital. It has laid out nearly 100 properties in first-tier cities nationwide, with more than 10,000 houses and services. It was founded on 2015 and is headquartered in Shanghai, China.

Waterdrop is a leading technology platform dedicated to insurance and healthcare service with a positive social impact. It's the largest independent third-party insurance platform in China in terms of life and health insurance first year premiums, distributed in 2020, according to iResearch. Through Waterdrop Insurance Marketplace and Medical Crowdfunding platforms, Waterdrop have built a massive social network of protection and support for people, raising awareness of insurance and ultimately providing insurance and healthcare service to consumers in China. It had listed on the New York Stock Exchange under the symbol “WDH” in May 2021.

Yimidida is an online logistics network based in Shanghai, China, that specializes in crowd-sourced delivery services, particularly to rural towns. Founded in 2015, the platform facilitates the delivery of products of various sizes to villages across China. Yimidida's offerings include payment collection, transport insurance, return receipts, and delivery tracking, all aimed at enhancing the efficiency of dispatch and truck deployment. This comprehensive logistics solution enables customers to receive their orders promptly, regardless of their location.

Antengene Corporation is a clinical-stage biopharmaceutical company based in Shanghai, China, founded in 2016. The company specializes in the development of innovative oncology therapies, focusing on treatments for various types of cancers, including hematologic malignancies and solid tumors. Antengene's product portfolio includes ATG-010 (selinexor), which targets XPO1 for treating multiple myeloma and DLBCL, and ATG-008 (onatasertib), an mTOR kinase inhibitor for advanced solid tumors. The company’s pipeline also features several compounds in various stages of development, such as ATG-016, ATG-527, ATG-019, and ATG-017, each targeting specific cancer pathways. In addition to its clinical programs, Antengene is involved in the discovery, development, manufacturing, and commercialization of first-in-class therapeutics, aiming to address unmet medical needs in the oncology field across Asia.

NetEase Cloud Music operates an online music platform and offers streaming services. It also develops music applications for smartphones. William Lei Ding founded NetEase Cloud in 2013, with its headquarters in Beijing in China. NetEase Cloud Music operates as a subsidiary of NetEase.

Lianlian Yintong Electronic Payment Co., Ltd, commonly known as Lianlian Pay, was established in 2003 and has grown to become the fourth largest non-banking third-party payment service provider in China, with a registered capital of RMB325 million. The company specializes in offering payment, clearing, and value-added mobile payment services, boasting over 60 payment licenses across various countries and regions. Lianlian Pay facilitates cross-border payments for approximately 100 sites linked to nearly 50 cross-border e-commerce platforms, extending its services to more than 100 countries. With a commitment to providing convenient, safe, and efficient payment solutions, Lianlian has accumulated a client base of over 1.1 million cross-border e-commerce stores and has established a significant presence in the global payment landscape. Additionally, it became one of the inaugural partners in the China (Hangzhou) Cross-border E-commerce Comprehensive Pilot Area, which was the first national-level pilot zone approved by the Chinese government.

Lianlian Yintong Electronic Payment Co., Ltd, commonly known as Lianlian Pay, was established in 2003 and has grown to become the fourth largest non-banking third-party payment service provider in China, with a registered capital of RMB325 million. The company specializes in offering payment, clearing, and value-added mobile payment services, boasting over 60 payment licenses across various countries and regions. Lianlian Pay facilitates cross-border payments for approximately 100 sites linked to nearly 50 cross-border e-commerce platforms, extending its services to more than 100 countries. With a commitment to providing convenient, safe, and efficient payment solutions, Lianlian has accumulated a client base of over 1.1 million cross-border e-commerce stores and has established a significant presence in the global payment landscape. Additionally, it became one of the inaugural partners in the China (Hangzhou) Cross-border E-commerce Comprehensive Pilot Area, which was the first national-level pilot zone approved by the Chinese government.

Klook is a prominent travel and leisure e-commerce platform that facilitates the discovery and booking of a wide variety of experiences and services for travelers. Users can explore and reserve activities such as tours, theme park tickets, cultural experiences, and adventure outings in numerous destinations. The platform also offers essential travel services, including public transport passes, airport transfers, car rentals, and SIM cards or eSIMs, ensuring seamless connectivity for users. Additionally, Klook allows travelers to book accommodations, making it a comprehensive solution for trip planning. Food enthusiasts can enhance their culinary experiences through dining reservations, food tours, and restaurant vouchers available on the platform.

Curon Biopharma is a developer of drugs intended designed for immuno-oncology therapies. The company's drugs consist of multiple class-leading cancer immunotherapeutic agents in the world that could address the shortcomings of current cancer treatment paradigm, enabling a physician to provide advanced cancer immunotherapies to their patients.

Incorporated in 2011, Megvii is committed to make greatest value for customers and the whole society with extraordinary technology. Megvii is an Artificial Intelligence company specialized in providing enterprises and developers with intelligent solutions and data services, and is dedicated to the mission of “Create machines that can see and think”. Based on its original deep learning system Brain++, Megvii seeks to build AI Engine, a core fundamental technology powering various AI application. It is leveraging on recognition, control, optimization and other algorithms to connect individuals, objects and scenarios, building a product platform of IoT OS. It is connecting standardized hardware like sensors, robots and personal devices with AI+IoT (AIoT), thus commercializing three application-oriented IoT brains on a large scale, namely, city brain, supply chain brain, and personal life brain. Megvii is building an operation system for the era of AIoT. Megvii is an AIoT solutions expert.

Trax provides offers in-store execution tools, market measurement services, and data science solutions for retail. Its mission is to enable brands and retailers to harness digital technologies' power to produce the best shopping experiences imaginable. Trax’s retail platform allows customers to understand what is happening on a shelf, in every store, all the time so they can focus on what they do best – delighting shoppers. Many of the world’s top CPG companies and retailers use Trax’s dynamic merchandising, in-store execution, shopper engagement, market measurement, analytics, and shelf monitoring solutions at scale to drive positive shopper experiences and unlock revenue opportunities at all points of sale. As a pioneer in computer vision, Trax continues to lead the industry in innovation and excellence through the development of advanced technologies and autonomous data collection methods. Trax is a global company with hubs in the United States, Singapore, and Israel, serving customers in more than 90 countries worldwide.

Brii Biosciences Limited is a biotechnology company focused on the research, development, and commercialization of medicines for chronic illnesses, particularly infectious diseases, liver, and lung conditions. Founded in 2018, the company operates from Durham, North Carolina, with additional offices in Shanghai, Beijing, and San Francisco. Brii Biosciences aims to provide innovative biopharmaceutical solutions tailored to the needs of Chinese patients, addressing public health challenges such as hepatitis B, HIV, and multidrug-resistant infections. The company leverages technology and data to enhance the Chinese healthcare system, ensuring better access to effective treatments. With a diverse pipeline of over ten product candidates, Brii Biosciences is committed to improving health outcomes for patients suffering from both infectious and central nervous system diseases.

A Fintech Company based in Beijing,China.

CStone Pharmaceuticals is a clinical-stage biotechnology company dedicated to developing and commercializing innovative immuno-oncology and molecularly targeted drugs aimed at addressing significant unmet medical needs in cancer treatment. Founded in 2015 and headquartered in Shanghai, China, the company has established a robust product pipeline that includes several late-stage clinical candidates, such as CS1001, a monoclonal antibody targeting programmed death ligand 1, and CS1003, which targets programmed death receptor. Other notable products include ivosidenib, avapritinib, and pralsetinib, along with a variety of additional investigational drugs for solid tumors and other cancer indications. CStone engages in strategic collaborations, including a licensing agreement with Numab Therapeutics for a tri-specific antibody and a clinical partnership with Bayer HealthCare to assess the efficacy of CS1001 in combination therapies. The company aims to enhance treatment options for cancer patients both in China and globally through its dedicated research and development efforts.

Viela Bio, Inc. is a clinical-stage biotechnology company based in Gaithersburg, Maryland, focused on the research and development of innovative treatments for severe inflammation and autoimmune diseases. The company's lead product candidate, inebilizumab, is a humanized monoclonal antibody targeting CD19, designed for conditions such as neuromyelitis optica spectrum disorder, kidney transplant desensitization, myasthenia gravis, and IgG4-related diseases. In addition to inebilizumab, Viela Bio is developing VIB4920, aimed at preventing kidney transplant rejection and treating Sjögren's syndrome, and VIB7734, which targets cutaneous lupus erythematosus. The company has formed a strategic partnership with Mitsubishi Tanabe Pharma Corporation to develop and commercialize inebilizumab for autoimmune diseases across several countries in Asia. Founded in 2017, Viela Bio is committed to addressing critical pathways underlying autoimmune diseases to improve patient outcomes.

Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer. The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.

LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.

iQIYI, Inc. is a prominent online entertainment platform in China, offering a wide range of services including internet video streaming, online gaming, live broadcasting, online literature, and e-commerce. Established in 2009 and headquartered in Beijing, the company operates under the iQIYI brand and has developed a comprehensive library of licensed and self-produced content across various genres such as movies, TV dramas, and animations. iQIYI generates revenue primarily through subscription services, boasting around 100 million paying subscribers and 500 million monthly active users. Additionally, the platform monetizes user-generated content through advertising, while also engaging in e-commerce via the iQIYI Mall, which specializes in entertainment-related merchandise. The company has diversified its offerings to include a live broadcasting service and a social media platform focused on entertainment. iQIYI faces competition from other streaming services such as Tencent Video and Alibaba's Youku, positioning itself as a leader in the rapidly evolving digital media landscape in China.

CStone Pharmaceuticals is a clinical-stage biotechnology company dedicated to developing and commercializing innovative immuno-oncology and molecularly targeted drugs aimed at addressing significant unmet medical needs in cancer treatment. Founded in 2015 and headquartered in Shanghai, China, the company has established a robust product pipeline that includes several late-stage clinical candidates, such as CS1001, a monoclonal antibody targeting programmed death ligand 1, and CS1003, which targets programmed death receptor. Other notable products include ivosidenib, avapritinib, and pralsetinib, along with a variety of additional investigational drugs for solid tumors and other cancer indications. CStone engages in strategic collaborations, including a licensing agreement with Numab Therapeutics for a tri-specific antibody and a clinical partnership with Bayer HealthCare to assess the efficacy of CS1001 in combination therapies. The company aims to enhance treatment options for cancer patients both in China and globally through its dedicated research and development efforts.

COFCO is a leading supplier of agricultural products and services based in Beijing, China. The company operates across various sectors within the agricultural and food industry, focusing on the trade, processing, and distribution of commodities such as grain, edible oils, sugar, and cotton. COFCO plays a crucial role in connecting domestic markets with international suppliers, serving as a key channel for the import and export of bulk agricultural products like wheat, corn, rice, and sugar. The company is committed to utilizing renewable natural resources to provide healthy and nutritious food while enhancing living standards and social prosperity. In addition to its core activities, COFCO is involved in various sectors, including real estate, hospitality, non-grain bio-energy, packaging, and finance, thereby diversifying its business portfolio and contributing to economic growth.

LY.com allows users to search for places of interest at the local and city levels. LY.com pinpoints the right spots within a few clicks. Every place of interest comes with user reviews. If users are satisfied with the reviews, they can purchase tickets directly on the site. The company's goal is to become the leading service provider of leisure travel, making it easier for customers to enjoy travelling.

Berry Genomics is a biotechnology company focused on the development and commercialization of genomic technologies for life sciences and clinical applications. The company specializes in next generation sequencing (NGS) tests aimed at detecting genetic diseases and cancers throughout various life stages, from preconception to adulthood. In addition to its testing services, Berry Genomics offers gene sequencing detection equipment, contributing to advancements in genetic research and diagnostics. Through its innovative approach, the company plays a significant role in the evolving field of genomics.

Alibaba Group is the largest online and mobile commerce company globally, primarily known for its extensive e-commerce platforms that connect buyers and sellers. It operates notable marketplaces in China, including Taobao, which focuses on consumer-to-consumer transactions, and Tmall, which caters to business-to-consumer interactions. The company's core business lies in its China commerce retail division, which is a significant source of cash flow. In addition to retail and wholesale transactions, Alibaba also generates revenue from various sectors, including international commerce, local consumer services, cloud computing, digital media and entertainment, and logistics through its Cainiao network. Alibaba's diverse portfolio positions it as a key player across multiple industries, including retail, logistics, and technology.